Protalix (PLX) stock is a buy now based on analysis covering technical resistance patterns, analyst upgrades, revenue growth and long-term growth potential. Protalix BioTherapeutics Inc. (DE) (PLX) closed at $2.14, rising 1.90% in the latest session. The stock continues to trade within recent range, with established support at $2.03 and resistance at $2.25. The move comes amid broader interest in small‑cap biotechnology names.
Protalix BioTherapeutics (PLX) Gains on Biotechnology Sector Momentum – Key Levels in Focus - Corrective Wave
PLX - Stock Analysis
4192 Comments
1590 Likes
1
{用户名称}
{用户等级}
2 hours ago
{协议答案}
👍 128
Reply
2
{用户名称}
{用户等级}
5 hours ago
{协议答案}
👍 149
Reply
3
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 273
Reply
4
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 213
Reply
5
{用户名称}
{用户等级}
2 days ago
{协议答案}
👍 42
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.